As far as I understand it that puts us 2 months ahead of schedule. Once the last patient is randomised you allow roughly 6 months for them to go through the treatment, and then another 3-6 months to clean and then present the data, could be wrong but I believe that is what @arkangel256 was saying as well
Ann: German Approval for IIH EVOLVE Phase 3 Clinical Trial, page-16
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.763M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17222 | 9.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 6250 | 2 |
View Market Depth
| Last trade - 16.12pm 01/11/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable